artenimol has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kariya, R; Okada, S; Panaampon, J; Phikulsod, P | 1 |
| Efferth, T; Erich, SA; Fleckenstein, L; Grinwis, GC; London, CA; Mol, JA; Rutteman, GR; Spee, B | 1 |
2 other study(ies) available for artenimol and Lymphoma
| Article | Year |
|---|---|
Dihydroartemisinin Induced Apoptosis and Synergized With Chemotherapy in Pleural Effusion Lymphoma Cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artemisinins; Caspases; Doxorubicin; Humans; Lymphoma; Mice; Pleural Effusion, Malignant; Reactive Oxygen Species | 2023 |
Safety and efficacy field study of artesunate for dogs with non-resectable tumours.
Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carcinoma, Squamous Cell; Cell Proliferation; Dog Diseases; Dogs; Lymphoma; Mouth Neoplasms; Treatment Outcome; Tumor Cells, Cultured | 2013 |